Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong‐Lyel Roh(CHA University Bundang Medical Center), Daiha Shin(Ulsan College)
Cited by 650
Related Papers
Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer
|Redox Biology|2020|192
Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis
|Theranostics|2020|123
Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer
|Oncotarget|2014|117
PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
|Journal of Experimental & Clinical Cancer Research|2021|99
Hederagenin Induces Apoptosis in Cisplatin‐Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2‐ARE Antioxidant Pathway
|Oxidative Medicine and Cellular Longevity|2017|67